FDA Approved: NOXAFIL — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approves NOXAFIL (posaconazole) through Merck's original NDA. The approval recognizes posaconazole for prevention and treatment of invasive fungal infection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Invasive Candidiasis
• Mucormycosis

Drugs mentioned

• NOXAFIL (POSACONAZOLE)

Snippet

ORIG AP for NOXAFIL (POSACONAZOLE)